UniProt P18465
HLA class I histocompatibility antigen, B-57 alpha chain (P18465)
HLA class I histocompatibility antigen, B-57 alpha chain (UniProt P18465): 47 experimental structures on GenesisL1, 1 ligand bound, 15 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P18465
- Protein
- HLA class I histocompatibility antigen, B-57 alpha chain
- Experimental structures
- 47
- Predicted models
- 0
- Ligands
- 1
- Pockets
- 15 · 2 records with a druggable one
Structures
47 records of P18465 in the MolNFT archive: 47 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2BVO | Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs… | x-ray diffraction | A | — | — |
| 2BVO | Structures of three HIV-1 HLA-B5703-peptide complexes and identification of related hlas… | x-ray diffraction | A | — | — |
| 2BVP | Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs… | x-ray diffraction | A | — | — |
| 2BVP | Structures of three HIV-1 HLA-B5703-peptide complexes and identification of related hlas… | x-ray diffraction | A | — | — |
| 2BVQ | Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs… | x-ray diffraction | A | — | — |
| 2BVQ | Structures of three HIV-1 HLA-B5703-peptide complexes and identification of related hlas… | x-ray diffraction | A | — | — |
| 2RFX | Crystal Structure of HLA-B*5701, presenting the self peptide, LSSPVTKSF | x-ray diffraction | A | — | — |
| 2RFX | Crystal structure of HLA-B*5701, presenting the self peptide, lsspvtksf | x-ray diffraction | A | — | — |
| 2YPK | Structural features underlying T-cell receptor sensitivity to concealed MHC class I… | x-ray diffraction | A | — | — |
| 2YPK | Structural features underlying T-cell receptor sensitivity to concealed MHC class I… | x-ray diffraction | A | — | — |
| 2YPL | Structural features underlying T-cell receptor sensitivity to concealed MHC class I… | x-ray diffraction | A | — | — |
| 2YPL | Structural features underlying T-cell receptor sensitivity to concealed MHC class I… | x-ray diffraction | A | — | — |
| 3UPR | HLA-B*57:01 complexed to pep-V and Abacavir | x-ray diffraction | A, C | — | — |
| 3UPR | HLA-B*57:01 complexed to pep-V and abacavir | x-ray diffraction | A, C | — | — |
| 3VH8 | KIR3DL1 in complex with HLA-B*5701 | x-ray diffraction | A, D | — | — |
| 3VH8 | KIR3DL1 in complex with HLA-B*5701 | x-ray diffraction | A, D | — | — |
| 3VRI | HLA-B*57:01-RVAQLENVYI in complex with abacavir | x-ray diffraction | A | — | — |
| 3VRI | HLA-B*57:01-rvaqlenvyi in complex with abacavir | x-ray diffraction | A | — | — |
| 3VRJ | HLA-B*57:01-LTTKLTNTNI in complex with abacavir | x-ray diffraction | A | — | — |
| 3VRJ | HLA-B*57:01-lttkltntni in complex with abacavir | x-ray diffraction | A | — | — |
| 3WUW | KIR3DL1 in complex with HLA-B*57:01.I80T | x-ray diffraction | A | — | — |
| 3WUW | KIR3DL1 in complex with HLA-B*57:01.I80T | x-ray diffraction | A | — | — |
| 3X11 | Crystal structure of HLA-B*57:01.I80N.L82R.R83G | x-ray diffraction | A | — | — |
| 3X11 | Crystal structure of HLA-B*57:01.I80N.L82R.R83G | x-ray diffraction | A | — | — |
| 3X12 | Crystal structure of HLA-B*57:01.I80N | x-ray diffraction | A | — | — |
| 3X12 | Crystal structure of HLA-B*57:01.I80N | x-ray diffraction | A | — | — |
| 5B38 | KIR3DL1*005 in complex with HLA-B*57:01 | x-ray diffraction | A | — | — |
| 5B38 | KIR3DL1*005 in complex with HLA-B*57:01 | x-ray diffraction | A | — | — |
| 5B39 | KIR3DL1*015 in complex with HLA-B*57:01 | x-ray diffraction | A | — | — |
| 5T6W | HLA-B*57:01 presenting sstrgisqlw | x-ray diffraction | A | — | — |
| 5T6X | HLA-B*57:01 presenting TSTTSVASSW | x-ray diffraction | A | — | 5 (best 0.68) |
| 5T6X | HLA-B*57:01 presenting tsttsvassw | x-ray diffraction | A | — | — |
| 5T6Y | HLA-B*57:01 presenting tstfedvkilaf | x-ray diffraction | A | — | — |
| 5T6Z | KIR3DL1 in complex with HLA-B*57:01-TW10 | x-ray diffraction | A | — | — |
| 5T70 | KIR3DL1 in complex with HLA-B*57:01 presenting tsnlqeqigw | x-ray diffraction | A | — | — |
| 5U98 | The crystal structure of a self-peptide complexed to Abacavir and HLA-B*57:01 | x-ray diffraction | A, D | 1KX | 10 (best 0.82) |
| 5U98 | The crystal structure of a self-peptide complexed to abacavir and HLA- B*57:01 | x-ray diffraction | A, D | 1KX | — |
| 5V5M | Crystal structure of HLA-B*5701 complex with HIV-1 gag derived peptide TW10 | x-ray diffraction | A, C | — | — |
| 5VUD | HLA-B*57:01 presenting lsspvtksw | x-ray diffraction | A | — | — |
| 5VUE | HLA-B*57:01 presenting ltvqvarvw | x-ray diffraction | A | — | — |
| 5VUF | HLA-B*57:01 presenting ltvqvarvy | x-ray diffraction | A | — | — |
| 6BXP | Crystal Structure of HLA-B*57:01 with a modified HIV peptide RKV-Kyn | x-ray diffraction | A | — | — |
| 6BXP | Crystal structure of HLA-B*57:01 with a modified HIV peptide rkv-kyn | x-ray diffraction | A | — | — |
| 6D29 | HLA-B*57:01 presenting tsmsfvprpw | x-ray diffraction | A | — | — |
| 6D2B | HLA-B*57:01 presenting lsdstardvtw | x-ray diffraction | A | — | — |
| 6D2R | HLA-B*57:01 presenting gsfdysgvhlw | x-ray diffraction | A | — | — |
| 6D2T | HLA-B*57:01 presenting lalltgvrw | x-ray diffraction | A | — | — |
Ligands
- 1KX · {(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol · in 2 records
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.